Free Trial

Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Rating of "Hold" from Brokerages

Health Catalyst logo with Medical background

Key Points

  • Health Catalyst, Inc. has received a consensus rating of "Hold" from twelve brokerages, with one sell recommendation, eight hold recommendations, and three buy recommendations.
  • The average target price for Health Catalyst shares among analysts is $4.5455, with recent price adjustments ranging from $4.00 to $10.00 by various firms.
  • Institutional investors own 85% of Health Catalyst's stock, with notable increases in holdings from several firms in the first quarter of the year.
  • Five stocks to consider instead of Health Catalyst.

Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have earned a consensus recommendation of "Hold" from the twelve research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $4.5455.

A number of brokerages have commented on HCAT. Piper Sandler lowered shares of Health Catalyst from an "overweight" rating to a "neutral" rating and decreased their price target for the company from $8.00 to $4.00 in a research note on Wednesday, August 27th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $4.00 target price on shares of Health Catalyst in a research note on Tuesday, October 7th. Wells Fargo & Company reduced their target price on shares of Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a research note on Monday, August 11th. BTIG Research reiterated a "neutral" rating on shares of Health Catalyst in a research note on Friday, September 5th. Finally, Stifel Nicolaus reduced their target price on shares of Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a research note on Friday, August 8th.

Read Our Latest Stock Report on HCAT

Health Catalyst Stock Performance

Shares of HCAT stock opened at $3.06 on Thursday. The firm has a market capitalization of $215.33 million, a PE ratio of -2.03 and a beta of 1.62. The firm has a fifty day simple moving average of $3.06 and a two-hundred day simple moving average of $3.62. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. Health Catalyst has a 12 month low of $2.52 and a 12 month high of $9.24.

Institutional Trading of Health Catalyst

Institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC boosted its holdings in shares of Health Catalyst by 195.2% in the 1st quarter. SG Americas Securities LLC now owns 80,825 shares of the company's stock worth $366,000 after buying an additional 53,443 shares during the last quarter. Dynamic Advisor Solutions LLC boosted its holdings in shares of Health Catalyst by 79.0% in the 1st quarter. Dynamic Advisor Solutions LLC now owns 45,585 shares of the company's stock worth $206,000 after buying an additional 20,116 shares during the last quarter. Omnia Family Wealth LLC purchased a new position in shares of Health Catalyst in the 1st quarter worth about $157,000. AMH Equity Ltd purchased a new position in shares of Health Catalyst in the 1st quarter worth about $1,144,000. Finally, MCF Advisors LLC purchased a new position in shares of Health Catalyst in the 1st quarter worth about $113,000. Institutional investors own 85.00% of the company's stock.

About Health Catalyst

(Get Free Report)

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

Read More

Analyst Recommendations for Health Catalyst (NASDAQ:HCAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Health Catalyst Right Now?

Before you consider Health Catalyst, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health Catalyst wasn't on the list.

While Health Catalyst currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.